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1. Introduction
According to the Institute of Medicine, hospital-acquired infection and the 
adverse event in hospitals are responsible for 44,000–98,000 deaths and account 
for $17–29 billion in the healthcare cost in the USA alone [1, 2]. The care of the 
patient in the intensive care unit (ICU) is expensive and poses a significant eco-
nomic burden on the healthcare [3, 4]. In the early part of the twentieth century, 
the intensive care units were taking care of patients with respiratory failure related 
to polio. With the advancement of technology and medicine, patients with multiple 
comorbidities are now being admitted in the ICU. A study by the World Health 
Organization (WHO) found that 51% of the patients in the ICU have infections [5].  
The risk of infection among patients on a mechanical ventilation is 6- to 21-fold 
higher. Surprisingly, the risk of ICU-acquired infections among low- and middle-
income countries was found to be 2–3 times higher than the ICU-acquired  infections 
among ICU patients in developed countries [5, 6]. With the advent of invasive 
monitoring and therapeutic devices, the incidence and prevalence of the infec-
tion have increased, and we have seen a significant increase in antibiotic use and 
multidrug-resistant (MDR) infections [7]. Infectious conditions, sepsis, and septic 
shock continue to be responsible for significant morbidity and mortality [7].  
Increased MDR infection has now become a global threat. Two million cases 
and 23,000 deaths each year are attributable to MDR infection in the USA alone, 
according to the Centers for Disease Control and Prevention (CDC) [8, 9]. In 
addition, inappropriate use of the antibiotics not only leads to increase in MDR 
but costs the healthcare $27–42 billion annually [8–10]. The central line-associated 
bloodstream infection (CLABSI) and catheter-associated urinary tract infection 
(CAUTI) have also been associated with significant nosocomial infection [11]. With 
significant efforts from the regulatory agency as well as the healthcare organiza-
tion and providers, a significant decrease in CLABSI and CAUTI has been seen 
[1, 12]. Education and antibiotic stewardship programs have been recommended 
by the CDC in 2014. In 2017, a survey by the National Healthcare Safety Network 
found that the number of hospitals with antibiotic stewardship program (ASP) 
has increased to 76.4%. Still 25% of the hospitals do not have ASP. As of September 
2019, the ASP is required by the Centers for Medicare and Medicaid Services (CMS) 
as part of the patient care reimbursement. With this new regulatory requirement by 
the CMS, it is expected that the ASP in hospitals will reach close to 100% [13].
In this book, we will also be addressing Legionnaires’ disease in detail. 
Legionnaires’ disease is a bacterial infection caused by Gram-negative bacteria, 
usually found in freshwater [14]. It can lead to severe pneumonia which can be fatal 
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(Legionnaires’ disease), but milder and subclinical infection forms (Pontiac fever) 
do exist [14, 15]. This disease is much more common than we think. Approximately, 
10,000 patients are hospitalized every year with Legionnaires’ disease in the USA 
alone. Legionnaires’ disease also creates a public health concern. It is usually trans-
mitted by inhaling the mist or via the cooling and water system issues. There have 
been numerous Legionnaires’ disease outbreaks over the decades, and the number 
seems to be increasing [16]. In the 1970s there were five outbreaks, in the 1980s 
seven, in the 1990s four, and in the 2000s ten. From 2010 to 2018, there were 23 
outbreaks. In the year 2019 alone, there were seven outbreaks (shown in Table 1). 
These reported outbreaks represent just the tip of the iceberg, as not all of them are 
reported. Moreover, reports from the developing countries are almost nonexistent. 
The fatalities from Legionnaires’ disease range from 0 to 75% [16]. The longevity, 
multiple invasive devices, increase in transplants, immunocompromised status, 
aging population, and increase in travels all pose a significant risk of increased 
outbreaks and high fatality rates. Research and education need to be done in this 
area. In this book, we will try to address the epidemiology, clinical and therapeutic 
as it pertains to disease as well as clinical scenario and treatment of Legionnaires’ 
disease among immunocompromised host.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
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Country City/state Source Cases Mortality Fatality rate
London, England [17] Westminster Via. water system 3 0 0
Belgium [18] Evergem Cooling towers 32 2 6.7%
USA [18] Ohio, New 
Jersey, Michigan
Unknown? Flint 
Michigan water 
crisis
32 6 18.75%
USA [18] Atlanta, Georgia 
(in Sheraton 
Hotel)
Water system 66 1 1.5%
USA [18] Fletcher, North 
Carolina
Hot tub display 141 4 2.83
Canada [18] Moncton, New 
Brunswick
Unknown 16 N/A —
USA [18] Batavia, Illinois 13 N/A —
Table 1. 
Selected Legionnaires’ disease outbreak in 2019.
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